Panel Critical of FDA's Asthma Drug Ruling
Experts Concerned About Limits on Long-Acting Asthma Drugs Such as Serevent and Foradil
Asthma Attacks Down Since LABAs Introduced continued...
No one exactly knows when LABAs can be discontinued, Busse says, "But you
don’t just turn them off as soon as you achieve control."
Inhaled steroids, the mainstay of asthma treatment, reduce airway
inflammation and mucus production, leading to better asthma control, fewer
symptoms and flare-ups, and reduced hospitalizations. But they do not relieve
asthma symptoms you already have.
LABAs relax muscles in the lung's airways, improving a patient's ability to
breathe freely and reducing asthma symptoms.
LABAs are approved to treat both people with asthma or with chronic
obstructive pulmonary disease (COPD). The new recommendations
only apply to the use of LABAs in the treatment of asthma.
The panel says it hopes to perform further studies to better define if and
when LABAs can be discontinued. And the FDA is requiring LABA makers to perform
additional studies of the drugs' safety.